# Omega-3 Fatty Acids, Neuroendocrine and Attention Deficit Hyperactivity Disorder (OMNeADHD)

> **NCT07364331** · NA · RECRUITING · sponsor: **China Medical University Hospital** · enrollment: 100 (estimated)

## Conditions studied

- ADHD
- Children
- Adolescents

## Interventions

- **DIETARY_SUPPLEMENT:** Omega-3
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT07364331
- **Lead sponsor:** China Medical University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-09-04
- **Primary completion:** 2026-07-31
- **Final completion:** 2026-07-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07364331

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07364331, "Omega-3 Fatty Acids, Neuroendocrine and Attention Deficit Hyperactivity Disorder (OMNeADHD)". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT07364331. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*